Cardiac Prosthetic Devices Market 2024-2028: Size and Complications associated with implantation of cardiac prosthetic devices; growth driven by the Product, Some of key Companies Positioned Strategically
The cardiac prosthetic devices market size by Product (Prosthetic heart valves and Implantable pacemakers) and Geography (North America, Europe, Asia, and Rest of World (ROW)), is forecast to increase by USD 5077.3 million. The market is expected to grow at a CAGR of 7.08% between 2024 and 2028.
- In the cardiac prosthetic devices market, the demand for heart valve replacements and pacemaker implantations is significant due to their role in addressing damaged heart valves and irregular heart rhythms. However, the market growth is restrained by the associated complications. Acute complications from pacemaker insertion occur within a day and have a higher occurrence rate than late complications of permanent pacemakers. Similarly, Transcatheter Aortic Valve Implantation (TAVI), a minimally invasive alternative to open aortic valve replacement, carries the risk of life-threatening complications during surgery and post-surgery. These complications pose a challenge to the expansion of the cardiac prosthetic devices market.
- The Cardiac Prosthetic Devices market encompasses innovative solutions designed to replace or support the heart's function. These devices, including pacemakers, implantable cardioverter defibrillators (ICDs), and left ventricular assist devices (LVADs), offer significant business opportunities due to the increasing prevalence of cardiovascular diseases. Market growth is driven by advancements in technology, rising healthcare expenditures, and an aging population. Companies focusing on research and development, strategic collaborations, and regulatory approvals will likely capture a larger market share.
Access the full report to know who are the other key countries segment-wise forecast and historic data
Some of the Key Companies:
- Abbott Laboratories
- Anteris Technologies Ltd.
- BIOTRONIK SE and Co. KG
- Boston Scientific Corp.
- Braile Biomedica
- Colibri Heart Valve LLC
- Cryolife Inc.
- Edwards Lifesciences Corp.
- Jc Medical Inc.
- JenaValve Technology Inc.
- Lepu Medical Technology Beijing Co. Ltd.
- LivaNova PLC
- Medtronic Plc
- Meril Life Sciences Pvt. Ltd.
- Merit Medical Systems Inc.
- MicroPort Scientific Corp.
- OrbusNeich Medical Co. Ltd.
- Shree Pacetronix Ltd.
- TTK Healthcare Ltd.
- Venus Medtech Hangzhou Inc.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/